Additionally, older age was associated with higher incidence of atrial fibrillation ... the recommended initial treatment of patients at risk for AF (stages 1 or 2) or with AF (stages 3 or ...

And the odds go up as you get older. If your heart races rather ... Heart rate control is a key way to manage atrial fibrillation. Doctors consider it one of the four pillars of AFib care.

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it. Whenever he’d overexert himself, he’d feel “different,” but it would go away with rest.

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Fast Five Quiz: Atrial Fibrillation Treatment and Management Do you know the latest and most effective prevention, management, and treatment strategies for patients with atrial fibrillation?

Dr. Ron Aviles explains available procedures and recovery time for those with heart and vascular conditions. Sponsored by Overlake Medical Center and Clinics.

Queen Sonja of Norway was admitted to the hospital on Jan. 11 following a flare-up of her atrial fibrillation while skiing.

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

Atrial fibrillation is the most common chronic arrhythmia ... Lower ventricular response rates in unmedicated older patients suggest underlying conducting system disease. [Kawaji T, et al.